Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation.
about
Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation.
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@ast
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@en
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@nl
type
label
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@ast
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@en
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@nl
altLabel
Long Term Survival and Continu ...... tient with BRAF V600K Mutation
@en
prefLabel
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@ast
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@en
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@nl
P2093
P2860
P356
P1476
Long Term Survival and Continu ...... ient with BRAF V600K Mutation.
@en
P2093
K Sahadudheen
M Iddawela
Md Rafiqul Islam
P2860
P304
P356
10.1155/2016/2672671
P577
2016-01-01T00:00:00Z